Home/Sequentify/Liran Shlush, MD, PhD

LS

Liran Shlush, MD, PhD

Board Member

Therapeutic Areas

Oncology Genetic Disorders Diagnostics

Sequentify Pipeline

Drug	Indication	Phase
NF1 Panel	Genetic testing for Neurofibromatosis type 1	Commercial
RAD21 Panel	Genetic testing for cohesin complex disorders	Commercial

Leadership Team at Sequentify

Tom Fleischer, PhD

Co‑Founder & CEO

Tamir Biezuner, PhD

Co‑Founder & CSO

Jacob Moran‑Gilad, MD, MPH, FESCMID

Dorit Sokolov, B.Pharm, MBA

Ravindra Majeti, MD, PhD

Valerie Darling

View full Sequentify profile